Scribe Therapeutics Inc.
Filed as SCRIBE THERAPEUTICS INC (COM), Equity As of 2026 Q3 so far: 135 of 140 managers we track have filed
- 2 Owners
- Max 0.1%
- $21M
- 2 new
In 2026 Q3 Cathie Wood and Farallon Capital Management opened positions in Scribe Therapeutics.
Who owns this now
Largest portfolio weights among holders, up to 0.1% (Cathie Wood, ARK Investment Management). Not free-float ownership.
Holders
Sorted by value, long equity only, as of 2026 Q3.
| History | |||||
|---|---|---|---|---|---|
| Cathie Wood, ARK Investment Management | New 0.08% | 786,921 | $14M | History | |
| Farallon Capital Management | New 0.03% | 380,000 | $7M | History |
Ownership over time
13Fs that reported it each quarter. Click a bar for that quarter’s holders.
Further reading
As an Amazon Associate, FollowTheFilings earns from qualifying purchases.
- How to Read a Financial Report (Tracy & Tracy) View on Amazon
- Financial Statements QuickStudy Laminated Guide View on Amazon